Imatinib Mesylate Suppliers & Bulk Manufacturers
Available Forms: Tablet / Capsule
Available Strengths: 50 mg, 100 mg, 400 mg
Reference Brands: Gleevec (EU & US), Veenat (India)
Category:
Oncology Cancer Care
Imatinib Mesylate is available in oral tablet form, with common strengths of 100 mg, 400 mg, and 50 mg. The drug is sold under the brand Gleevec® (by Novartis) and also in generic versions from manufacturers like Teva, Sandoz, and Mylan. It is widely used in the US and EU for treating cancers such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
Product Description:
Imatinib Mesylate is a targeted therapy used in oncology to treat chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other cancers. Available under the brand Gleevec® by Novartis and as generics, Imatinib is an essential tyrosine kinase inhibitor (TKI) used in cancer centers, hospitals, and oncology clinics. It blocks the action of abnormal proteins that contribute to cancer cell growth, making it crucial for effective cancer management. Available in oral tablets and generics, Imatinib Mesylate is widely sourced by B2B pharmaceutical wholesalers in the US and EU, ensuring reliable supply and GMP-compliant distribution for cancer treatment.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing